title: [Diagnosis and treatment of bone marrow edema syndrome of the hip and differential diagnosis from avascular necrosis of femoral head].
abstract: OBJECTIVE
  To observe the diagnosis and treatment of bone marrow edema syndrome and summarize its features, mechanisms and its differences from avascular necrosis of femoral head.
  
  
  METHODS
  From 2004.1, 19 patients (12 patients were males and 7 patients were females, with a mean age of (46.70 +/- 10.36) years) with bone marrow edema syndrome of hip treated with Ibandronate and physical therapy, as well as scored with Harris system before and after treatment.
  
  
  RESULTS
  Average score before treatment was (43.17 +/- 12.62), and (86.73 +/- 14.29) after treatment, and the difference was significant (P < 0.05).
  
  
  CONCLUSIONS
  Bone marrow edema syndrome of hip is different from avascular necrosis of the hip, it is a distinct clinical entity.
authors.affiliation: Rehabilitation Department, the Second Affiliated Hospital of Inner Mongolia Medical College, Huhehaote 010030, Neimenggu, China. pangziljf@yahoo.com.cn
authors.forename: Jian-Feng
authors.initials: JF
authors.lastname: Li
authors.forename: Jin-Yu
authors.initials: JY
authors.lastname: Yan
mesh_terms: D000328:Adult; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D005271:Femur Head Necrosis / Q000175:diagnosis* / Q000473:pathology; D006621:Hip Joint / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D000077557:Ibandronic Acid; D008297:Male; D008875:Middle Aged
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077557:Ibandronic Acid